Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
137.00
Ask:
144.00
Spread: 7.00 (5.109%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

14 Jul 2022 07:00

RNS Number : 4114S
Xaar PLC
14 July 2022
 

 

Xaar plc

 

Trading Update

 

Xaar plc ("Xaar", the "Group" or the "Company"), the leading inkjet printing technology group, today announces a trading update for the six months ended 30 June 2022.

 

 

TRADING

 

Continued strong trading and momentum

 

· Revenue for the period is expected to be approximately £37 million, representing an increase of 41% relative to H1 2021 (14% organic excluding FFEI and Megnajet) and 12% relative to H2 2021 (11% organic excluding Megnajet)

 

· Strong revenue growth with improved gross margins and successful cost management actions mean the Board expects the Group to be on track to report an adjusted profit for the current year in line with its expectations

 

Further operational and strategic progress across the Group

 

· Printhead division performed well with strong growth in Europe and US offsetting a Covid-related slowdown in China. We remain on track for the aqueous printhead launch in Q4 2022

 

· The new printbar product developed by FFEI, Xaar Versatex, was successfully launched, whilst the acquisition of Megnajet further strengthens the Group's vertical integration capability

 

· Product Print Systems business ("EPS") delivered a strong, improved performance with revenue and margin growth

 

Successfully mitigating cost inflation

 

· Further investment in inventory has allowed the Group to successfully mitigate cost inflation and increases supply chain resilience

 

· Sales price increases have further assisted in off-setting the effects of cost inflation

 

· Additional management initiatives are helping in reducing costs and increasing operational efficiency while cutting energy use supporting Xaar's 'net zero' commitments

 

 

BALANCE SHEET AND LIQUIDITY

 

The Group remains well capitalised with a strong balance sheet and cash position. Investment has been made in acquiring Megnajet and key capital projects together with increasing working capital to protect the Group's supply chain and ability to deliver products on time. Net cash at 30 June 2022, was £12.6 million, in line with management expectations.

 

 

John Mills, Chief Executive Officer, commented:

 

"We are really pleased to have achieved a strong performance in the first half of the year in line with our expectations. We are on target, seeing positive momentum continuing to improve performance across the Group.

 

We continue to make strategic and operational progress and remain on track to delivering long-term profitable growth.

 

Despite a continued uncertain macro-economic outlook, we remain confident and excited by the future and look forward to the launch of our aqueous printhead later in the year." 

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Tulchan Communications

Giles Kernick

Olivia Lucas

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKNBKCBKDCOD
Date   Source Headline
27th Mar 20077:00 amRNSDirector/PDMR Shareholding
21st Mar 20077:00 amRNSHolding(s) in Company
20th Mar 20071:38 pmRNSHolding(s) in Company
19th Mar 20074:02 pmRNSHolding(s) in Company
15th Mar 200711:29 amRNSDividend Record Date Amendmnt
15th Mar 20077:01 amRNSFinal Results
6th Mar 20076:30 pmRNSHolding(s) in Company
15th Feb 20077:01 amRNSNotice of Final Results
14th Feb 20077:01 amRNSOffer Talks Terminated
12th Feb 20076:22 pmRNSHolding(s) in Company
9th Feb 200712:02 pmRNSEPT Disclosure
9th Feb 200710:14 amRNSRule 8.3- Xaar PLC
8th Feb 200711:53 amRNSRule 8.3- Xaar PLC
7th Feb 200711:20 amRNSEPT Disclosure
5th Feb 200710:56 amRNSEPT Disclosure
2nd Feb 200712:12 pmRNSEPT Disclosure
2nd Feb 200710:35 amRNSRule 8.3- Xaar PLC
31st Jan 200712:38 pmRNSRule 8.3- Xaar PLC
31st Jan 200712:02 pmRNSRule 8.3- Xaar PLC
30th Jan 20071:07 pmPRNRule 8.3 - XAAR PLC
30th Jan 200710:48 amRNSRule 8.3- Xaar PLC
29th Jan 20079:46 amRNSRule 8.3- Xaar PLC
25th Jan 200710:32 amRNSEPT Disclosure
25th Jan 200710:21 amRNSRule 8.3- Xaar PLC
24th Jan 200710:06 amRNSRule 8.3- Xaar PLC
23rd Jan 20079:19 amRNSRule 8.3- Xaar PLC
22nd Jan 200711:32 amRNSRule 8.3- Xaar PLC
19th Jan 20079:45 amRNSRule 8.3- Xaar
17th Jan 200711:54 amRNSEPT Disclosure
16th Jan 200711:48 amRNSEPT Disclosure
16th Jan 20079:52 amRNSRule 8.3- Xaar PLC
15th Jan 200711:01 amRNSRule 8.3- Xaar PLC
12th Jan 200710:30 amRNSEPT Disclosure
29th Dec 20069:20 amRNSAdditional Listing
28th Dec 200611:46 amRNSEPT Disclosure
28th Dec 20068:50 amRNSAdditional Listing
27th Dec 20069:03 amRNSAdditional Listing
22nd Dec 20068:32 amRNSAdditional Listing
21st Dec 200612:28 pmRNSEPT Disclosure
21st Dec 200610:30 amRNSAdditional Listing
21st Dec 200610:29 amRNSAdditional Listing
20th Dec 20064:22 pmRNSHolding(s) in Company
19th Dec 200612:21 pmRNSTotal Voting Rights
19th Dec 200612:02 pmRNSEPT Disclosure
18th Dec 20061:34 pmRNSEPT Disclosure
18th Dec 20061:07 pmRNSRule 8.3- Xaar PLC
15th Dec 200612:45 pmRNSEPT Disclosure
12th Dec 20061:02 pmRNSEPT Disclosure
11th Dec 200611:52 amPRNRule 8.3
8th Dec 200612:29 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.